Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Stomatitis 2Mouth Diseases 2

Interventions

Cisplatin 6Radiotherapy, Intensity-Modulated 4Saline Solution 3Injections 3golotimod 2avasopasem manganese 2Water 2Vitamin B 12 2Standard of Care 2RRx-001 2Practice Guidelines as Topic 2Gentamicins 2Fibroblast Growth Factor 7 2FGF20 protein, human 2Drug Therapy 2samital 1regramostim 1peppermint oil 1meclocycline 1hydrated silica gel-based toothpaste 1holy basil leaf extract 1cobiprostone 1clazakizumab 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Stomatitis × FGF20 protein, human × Clear all
NCT00323518 2016-04-13

A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis

Celldex Therapeutics

Phase 2 Completed
390 enrolled

Mouth Diseases, Stomatitis

NCT00104065 2016-03-15

Safety and Efficacy of CG53135-05 in the Prevention of Oral Mucositis in Patients Receiving Bone Marrow Transplant

Celldex Therapeutics

Phase 2 Completed

Mouth Diseases, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡